A detailed history of Larson Financial Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Larson Financial Group LLC holds 338 shares of DXCM stock, worth $27,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
338
Previous 333 1.5%
Holding current value
$27,053
Previous $37,000 40.54%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $320 - $580
5 Added 1.5%
338 $22,000
Q2 2024

Aug 02, 2024

BUY
$110.31 - $140.45 $2,647 - $3,370
24 Added 7.77%
333 $37,000
Q4 2023

Feb 01, 2024

BUY
$75.49 - $124.16 $75 - $124
1 Added 0.32%
309 $38,000
Q1 2023

May 04, 2023

BUY
$104.0 - $122.92 $832 - $983
8 Added 2.67%
308 $35,000
Q3 2022

Nov 03, 2022

BUY
$76.35 - $94.18 $22,905 - $28,254
300 New
300 $24,000
Q1 2022

May 05, 2022

SELL
$94.08 - $130.2 $282 - $390
-3 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$129.87 - $162.82 $389 - $488
3 New
3 $2,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.